Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Reproductive morbidity among Iranian women; issues often inappropriately addressed in health seeking behaviors

  • Fahimeh Ramezani Tehrani1,
  • Masoumeh Simbar2, 3Email author and
  • Mehrandokht Abedini4
BMC Public Health201111:863

DOI: 10.1186/1471-2458-11-863

Received: 19 April 2011

Accepted: 14 November 2011

Published: 14 November 2011

Abstract

Background

Reproductive morbidity has a huge impact on the health and quality of life of women. We aimed to determine the prevalence of reproductive morbidities and the health seeking behavior of a nationally representative sample of Iranian urban women.

Methods

A sample of 1252 women, aged 18-45 years, was selected using the multi stage, stratified probability sampling procedure. Data were collected through interviews and physical, gynecological and ultrasonographic examinations.

Results

Reproductive tract infection (RTIs), pelvic organ prolapse (POP) and menstrual dysfunction were the three main groups of morbidities with a prevalence of 37.6%, 41.4% and 30.1%., respectively. Our study demonstrated that 35.1, 34.5 and 9.6 percent of women experienced one, two or these reproductive organ disorders mentioned, respectively, while 20.6 percent of participants had none of these disorders. Findings also showed that the majority of women who suffered from reproductive morbidities (on average two out of three) had not sought appropriate care for these except for infertility.

Conclusions

Reproductive health morbidities impose a large burden among Iranian women and have negative impact on their reproductive health and wellbeing.

Background

The third millennium development program emphasized maternal health, which can be assessed by maternal mortality ratio. However, for every woman who dies, approximately twenty others face serious or long-lasting morbidities [1]. As a result, every year an estimated 50 million women are affected by maternal morbidity and for at least 18 million of them these morbidities become long-term and are often debilitating [2]. According to WHO estimates, reproductive ill health accounts for 33% of the total burden of disease in women as compared to 12.3% for men [3]

Reproductive morbidity has defined as any condition or dysfunction of the reproductive tract, or any morbidity which is a consequence of reproductive behavior including pregnancy, abortion, childbirth, or sexual behavior [4]. Reproductive morbidity has a huge impact on the health and quality of life of women and it should be prioritized as such [5, 6]. Although there are several hospitals based studies concerning maternal health, the number of community based studies is limited [712]. Reproductive morbidities may be overestimated in hospital based setting, as hospital attendants are usually those with health complaints. On the other hand, the burden of these morbidities can be influenced by the culture of silence surrounding these disorders, in particular, in countries with conservative backgrounds [7, 13]. Besides that many women who suffered from reproductive organ disorders had not sought appropriate care and women's health seeking behavior is been influenced by many factors [1416].

There is no information on the burden of reproductive health problems and health seeking behavior of the Iranian women except for one study on Qashqa'i women [17]. We aimed to assess the scale of reproductive morbidities and their health seeking behavior in a nationally representative sample of urban Iranian women.

Methods

This community-based descriptive study was performed between 2008 and 2010 to determine the prevalence of reproductive morbidity among Iranian women of reproductive age.

Sample size was calculated based on these parameters: P = 0.085 [5], α = 0.95, d = 0.025, cluster design effect = 2 and a non response rate = 0.15. A stratified, multistage probability cluster sampling method, with a probability in proportion to size procedure, was used. Otherwise, the subjects of the present study were recruited using cluster sampling method from 4 randomly selected provinces of Iran. For the selection of these provinces at first we divided the provinces to 4 geographic subgroups and after that one province from each of this subgroup was randomly selected. The selected provinces were Ghazvin, Kermanshah, Golestan and Hormozgan that located in central, west, north and south of Iran, respectively. Subsequently the proportion of required samples in each province was calculated using data available on the total number of women age 18-45 who lived in urban area of each of those provinces. We considered 7 household in each cluster; based on 1 day performance capacity of the data collection group. The number of cluster in each province was calculated by dividing the total number of required samples in each province to 7. The household list is available in the health department of each province and usually updated annually. Using this list, the sampling interval (k) was calculated by dividing the total number of households to the requested number of cluster in each province. After that one number between 1-k was randomly selected, this number was the number of the 1st selected household. Next household was picked out from the list by adding K to the number of 1st recruited household. This process was continued till all of the requested clusters were selected. (selecting the cluster was made systematically.

A checklist questionnaire, based on the inclusion and exclusion criteria was completed at subjects' homes. Menopausal women and pregnant women were excluded, as a result of which 1236 women fulfilled our inclusion criteria and were invited to a referral clinic in each province for a comprehensive interview and physical exam. Of these eligible women 1117 complete our study procedure, while the reminder dropped out.

Pairs of trained staff members of local medical universities/schools served as interviewers, and a trained supervisor monitored the process in each district. A standard questionnaire including information on socio-demographic and reproductive variables as well as women's self reporting of particular signs and symptoms of lower reproductive tract infection (RTIs), pelvic organ prolapse (POP), menstrual dysfunction during the previous 6 months and their health seeking behavior was completed, during face-to-face interviews by trained midwives.

The content validity of the questionnaire was assessed by 15 gynecologists and reproductive health experts of Shahid Beheshti and Tehran Medical Science universities. The reliability of the questionnaire was assessed using test-retest and inter-rater methods, both confirmed by r = 0.91 and r = 0.85, respectively.

All participants underwent clinical examinations, where body weight, height, waist (WC), hip circumferences (HC) and blood pressure were measured. Gynecological assessment included a speculum examination and bimanual pelvic examination was carried out for all married women by a single gynecologist in each province. The external genitalia, perineum and anal sphincter function were examined. To improve validity and reliability of the medical examination the gynecologists used standard diagnostic protocols, developed during the pilot study by means of the standard protocol for assessment of pelvic organ prolapse and genital infection [18, 19]. The long time primary infertility, dysmenorrheal, premenstrual syndrome, meno-metroragia and oligomenorrhea were defined according to the standard definition presented in table 1[2024]. Self treatment or treatments recommended by non specialists were defined as traditional interventions and standard treatment currently used was considered as modern interventions.
Table 1

Definition for reproductive morbidities according to the women's complaints/physical/ultrasonographic examinations and their denominators for analysis

Morbidity

Subgroup

Definition

Denominator

 

Dysmenorrhea

Pain with menstrual periods that interfere with women's normal activities [18]

Menstrual women not currently using hormonal contraceptives

Menstrual dysfunctions

Premenstrual syndrome

one or more disturbing affective or somatic symptoms that have occurred during the 5 days before menses in each of 3 previous menstrual cycles

Menstrual women not currently using hormonal contraceptives

 

Meno-metroragia

Spotting or prolonged bleeding in the previous 3 months

Menstrual women not currently using hormonal contraceptives

 

Oligomenorrhea

vaginal bleeding episodes more than 35-day intervals

Menstrual women not currently using hormonal contraceptives

Long time primary infertility

-

having the history of trying to conceive for at least one year without success despite of regular sexual intercourse and no use of contraception [17]

Ever Married women had willingness to conceive and not used contraception some times in her life

 

Abnormal vaginal discharge

Response "yes" to this question" Do you have Abnormal vaginal discharge in term of bad odor or abnormal color?"

All participants

Reproductive tract infections(study subjects)

Itching or irritation in vaginal area

Response "yes" to this question" Do you have Itching or irritation in vaginal area?"

All participants

 

Genital ulcers or sores

Response "yes" to this question" Do you have genital ulcers or sores in vaginal area?"

All participants

Reproductive tract infections (clinical examination)

-

guidelines of syndromic approach for reproductive tract infections using speculum [19]

Ever Married women

Dyspareunia

Painful sexual intercourse

Response "yes" to this question" Do you usually feel any pain in your vagina or genital area during or after sexual activity?"

Women with sexual intercourse

 

Stress incontinence

Response "yes" to this question "Do you usually leak urine with a cough, sneeze or laugh?"

Ever Married women

 

Incomplete urination

Response "yes" to this question" Do you usually have to push up in the vaginal area with your fingers to complete urination?"

Ever Married women

Pelvic organ prolapse(study subjects)

Incontinence gas passage

Response "yes" to this question" Do you usually lose gas from the rectum beyond your control?"

Ever Married women

 

Incomplete defecation

Response "yes" to this question" Do you usually need to help stool out by pushing with a finger in the vagina or rectum?"

Ever Married women

 

Looseness of vaginal opening

Response "yes" to this question" Do you Do you feel that your vaginal opening is too loose?

Ever Married women

Pelvic organ prolapse(clinical examination

-

descending of anterior and/or posterior vaginal wall and or uterus below their normal position using the standard protocol [18]

Ever Married women

Pelvic mass(clinical examination)

 

the presence of adnexal and/or uterus mass on the bimanual examination

Ever Married women

Pelvic mass(ultrasonographic examination)

 

the presence of adnexal and/or uterus mass on the ultrasonographic examination

All participants

All of the study subjects were invited for transvaginal or transabdominal ultrasound scans of the ovaries, performed by an experienced sonographer in each province, using the 3.5-MHz transabdominal and 5-MHz transvaginal transducer; all scans were assessed by a single sonographer. The definition for each reproductive morbidity and their denominators for analysis were presented in table 1.

The ethical review board of Ministry of Health and Medical Education of Iran approved the study and informed consent was obtained from all subjects.

Statistical analysis

Data was analyzed using Stata software version 10. The prevalence of various reproductive morbidities and its 95% CI were calculated with adjustment for cluster sampling method.

Results

A study checklist was completed for 1252 women, aged 18-45 years, of whom 1236 met our inclusion criteria; of these eligible women 1117 ones completed the study procedure. The characteristics of the study subjects are summarized in table 2. Eighty-seven percent of participants were currently married, divorced or widowed, 85.1 percent of women were housewives and the remainder was employed (part-time or full-time); 26 percent of ever married participants had experienced miscarriage once or more and one percent of them had history of recurrent abortion. The prevalence of life time primary infertility was 8.3 percent (95% CI 6.6%-10.0%). Table 3 shows the finding on clinical and ultrasonographic examinations. The three most common diagnosed reproductive morbidities using standard definition were menstrual disorders, POP and RTIs with a prevalence of 41.4, 37.6 and 30.1 percent, respectively (Tables3 and 4). Results also demonstrated that 35.1, 34.5 and 9.6 percent of women experienced one, two or all of these three morbidities, respectively and only 20.6 percent of participants had none of these symptoms. In ultrasonographic report 5 percent of women had pelvic mass, with only one out of every five being correctly diagnosed during bimanual pelvic examinations.
Table 2

Characteristics of participants

Characteristic

 

Mean ± SD/Percent

Age(years)

Age

33.2 ± 7.7

 

Age at marriage

19.7 ± 3.3

 

Age at 1st pregnancy

19.9 ± 3.9

 

Spouse's age

24.8 ± 5.5

Marital status (%)

Married

84.1

 

Single

13.0

 

Widowed/divorced

2.9

Education (years)

-

8.9 ± 4.1

Employment status (%)

Unemployment

85.1

 

Part time

3.5

 

Fulltime

11.4

*Reproductive history (Number)

Gravity

2.8 ± 1.6

 

Parity

2.5 ± 1.5

 

Abortion

0.3 ± 0.7

*Women with cesarean section (%)

 

19.4

Anthropometric parameters

BMI(kg/m2)

26.9 ± 4.9

 

Waist circumferences(cm)

85.2 ± 12.0

 

Hip circumferences(cm)

105.3 ± 11.3

 

Waist/hip ratio

0.81 ± 0.09

Blood pressure(mm/gH)

Systolic

108.4 ± 13.8

 

Diastolic

68.4 ± 11.3

*These data are related to ever married women

Table 3

Finding on clinical and ultrasonographic examinations and specific diagnosis using standard definition

Finding

 

Number of women/total

%

Body mass index

< 18 kg/m2

26/1117

2.3

 

18-25 kg/m2

390/1117

34.9

 

25-30 kg/m2

426/1117

38.2

 

> 30 kg/m2

275/1117

24.6

Inspecting

perineum

Inflammation

98/967

10.1

 

Purulent vaginal discharge

159/967

16.4

 

Ulcer

5/967

0.5

 

Wart

2/967

0.2

Speculum examination

Mucopurulent cervical discharge

169/967

17.5

 

Cervix bleed on touching

32/967

3.3

 

Cervical inflammation

107/967

11.1

 

Cervical laceration

43/967

4.4

 

Cervical polyp

6/967

0.6

*Reproductive tract infections

Using specific definition

364/967

37.6%(95% CI 34.5-40.7)

Pelvic organ prolapse

Stage 1

296/967

30.6

 

Stage 2

77/967

8.0

 

Sage 3

24/967

2.5

 

Stage 4

3/967

0.3

**Total Pelvic organ prolapse

Using specific definition

391/967

41.4(95% CI 39.8- 44.5)

Bimanual pelvic examination

Cervical motion tenderness

60/967

6.2

 

Uterus enlarged

42/967

4.3

 

Uterine fibroid

9/967

0.9

 

Adnexal mass

21/967

2.2

 

Total Pelvic mass correctly diagnosed

14/929

1.5(95% CI 0.7-2.3)

Ultrasonographic findings

Uterus enlarged

108/929

11.2

 

Endometrial Polyp

4/929

0.4

 

Polycystic ovaries

156/929

16.8

 

Uterine fibroid

33/929

3.6

 

Adnexal mass

38/929

4.1

 

Total Pelvic mass

71/929

7.6(95% CI: 5.9-9.3)

* Defined using the standard protocol for assessment of the genital infection (references no. [19])

** defined using the standard protocol for assessment of pelvic organ prolapse (reference no. [18])

Table 4

Proportion of women reporting reproductive organ symptoms, their health seeking behavior and specific diagnosis using standard definition

Morbidity

Symptoms

Percentage of women

ØType of intervention (%)

  

With aliment

Sought intervention

¥Traditional intervention

¥¥modern intervention

Menstrual dysfunctions

Dysmenorrhea

185/1047

(17.7%)

160/1047

(15.3%)

98/185

(53.0%)

62/185

(33.5%)

 

Premenstrual syndrome

130/1047

(12.4%)

26/1047

(2.5%)

22/130

(16.9%)

4/130

(3.1%)

 

Meno-metroragia

236/1047

(22.5%)

79/1047

(7.5%)

53/236

(22.5%)

26/236

(11.0%)

 

Oligomenorrhea

59/1047

(5.6%)

42/1047

(4.0%)

10/59

(16.9%)

32/59

(54.2%)

*Total Menstrual dysfunctions

-

336/1117

(30.1%)

170/1117

(15.2%)

101/336

(30.1%)

69/336

(20.5%)

Infertility

-

72/869

(8.3%)

63/869

(7.2%)

9/72

(12.5%)

54/72

(75.0%)

Reproductive tract infections

Abnormal vaginal discharge

256/967

(26.5%)

146/967

(15.1%)

98/256

(38.3)

48/256

(18.8%)

 

Itching or irritation in vaginal area

129/967

(13.3%)

44/967

(4.5%)

40/129

(31.0%)

4/129

(3.1%)

 

Genital ulcers or sores

11/967

(1.1%)

11/967

(1.1%)

1/11

(9.1%)

10/11

(90.9)

**Reproductive tract infections

-

364/967

(37.6%)

152/967

(15.7%)

102/364

(28.0%)

50/364

(13.7%)

Dyspareunia

Painful sexual intercourse

103/917

(11.2%)

18/917

(2.0%)

8/103

(7.8%)

10/103

(9.7%)

Pelvic organ prolapse

Stress incontinence

151/967

(15.6%)

33/967

(3.4%)

8/151

(5.3%)

25/151

(16.6%)

 

Incomplete urination

80/967

(8.3%)

22/967

(2.3%)

6/80

(7.5%)

16/80

(20%)

 

Incontinence gas passage

130/967

(13.4%)

42/967

(4.3%)

12/130

(9.2%)

30/130

(23.1%)

 

Incomplete defecation

22/967

(2.3%)

17/967

(1.8%)

7/22

(31.8%)

10/22

(45.5%)

 

Looseness of vaginal opening

140/967

(14.5%)

89/967

(9.2%)

41/140

(29.3%)

45/140

(32.1%)

***Total Pelvic organ prolapse

-

400/967

(41.4%)

154/967

(15.9%)

82/400

(20.5%)

72/400

(18%)

Ø women who used only traditional methods were considered as the users of traditional intervention; and women who used only modern methods or both traditional and modern methods were considered as the users of modern intervention

* Defined according to the standard definition (references no. 20-24)

** Defined using the standard protocol for assessment of the genital infection (references no.19)

*** Defined using the standard protocol for assessment of pelvic organ prolapse (reference no.18)

¥ Defined as Self treatment or treatments recommended by non specialists

¥¥ Defined as sing standard treatment protocol recommended by a specialist.

Table 4 demonstrates the proportion of women reporting reproductive organ symptoms, their diagnosis using standard protocol and their health seeking behavior. On average two out of three of women suffered from reproductive morbidities had not sought appropriate care except infertility, for which 61 out of 80 women with long time infertility had received current standard interventions (Table 4). Results demonstrated that 25 out of 151 women with stress incontinence sought standard interventions, whereas the others used traditional methods or ignored the symptom, considering to be a usual symptom for any women who had given birth (Table 4).

Discussion

This is the first community based study aiming to demonstrate the prevalence of reproductive morbidities and the health seeking behavior among Iranian reproductive aged women. The results revealed a high frequency of these morbidities and a culture of silence observed in the health seeking behavior of such women with ailments that need to be addressed appropriately in national health care screening program.

Menstrual problems, pelvic organ prolapse and reproductive tract infections were the three most common morbidities, with 79.4 percent of the participants having at least one of these symptoms. The prevalence of RTIs was 37.6% in the present study, while it was 70% in China [8], 41% in Egypt [8] and 9% in rural areas of Lebanon [25]. The prevalence of lower RTIS and upper RTIs in Oman were 22 and 3.7 percent respectively [26]. The prevalence of RTIs not only depends on the biologic characteristics of the microorganism but it is highly influenced by the communities' sexual behavior, the recruitment of study subjects, type of the study and the method for identification of these infections. Therefore the differences in the reported prevalence in these various countries can be partly explained by the different methodologies and diverse sexual behaviors, e.g. in a small rural community premarital and extramarital sexual relations are not acceptable as a result of which the rate of reproductive RTIs is low [25]. Furthermore RTIs were defined using a symptomatic approach or diagnosed based on gynecological examination or microorganism observations in different studies, in the present study we diagnosed RTIs based on guidelines of syndromic approach for genital infections as a result this limits its comparability with those other studies that use other tools for identification of genital infections. A clear and contemporaneous method for screening and recognition of RTIs is essential for improving the comparability and potentially the value of published research [11, 27, 28]. The similarities between RTIs' symptoms and their own gynecological exam used in our study prove the suitability of using a simple questionnaire for screening of genital infections in a resource limited area, for prevention of their severe consequences, as it has been reported before [19, 29, 30]. In spite of the high prevalence of RTI in the present study, many women did not seek care or proper treatment, as reported elsewhere [29].

The prevalence of pelvic organ prolapse in our study was 41.4 percent; it was 56% in Egypt [7] and 10% in Oman [26]. Clinical based studies showed a prevalence of 75 percent of POP [31, 32], this high prevalence may be due to referring of symptomatic women to the clinics, furthermore its prevalence is influenced by several demographic and reproductive factors [33]. A questionnaire was developed for assessment of POP and its sensitivity and specificity was investigated [32, 34], in this study, its modified and simple form was used for assessment of POP at the community level and it appropriately diagnosed over two thirds of women suffering from POP. Active screening of POP at the community level is highly recommended as its mild type can be easily treated using simple interventions including pelvic floor muscle training with biofeedback and bladder training, which have a great impact on the quality of life women have [35].

Meno-metroragia is the leading cause of two third of hysterectomies [36]. Various studies demonstrate different prevalences of abnormal uterine bleeding, possibly because of disagreement in its definitions [37], type of the study and the recruitment of its study subjects. Our study demonstrated that although 21.1 percent of women had meno-metroragia, only one out of every ten of them seeking modern interventions. Active screening of these women and referring of complicated cases could significantly reduce secondary complications such as anemia, a major indirect cause of maternal mortality [38]

In the present study, the majority of women with reproductive morbidities had not sought appropriate care except for infertility; this might be because such disorders were considered normal by these women as they were prevalent or because of they were not aware that the condition was curable. However the majority of our infertile women (76.1%) had sought care, which could be because of being infertile can socially stigmatize a women and cause marital problems, particularly in conservative communities where a woman's status depends directly on her fertility [20, 39]. These infertile women commonly face severe socioeconomic problems and their marriages are threatened by divorce, forcing them to seek treatment to save their marriages. Many factors impact the reproductive care- or treatment - seeking behavior of women, such as lack of privacy in reproductive health care services in rural Ghana [16], fear of social discrimination or shying away from genital examinations in Laos [29] and the impact of these symptoms on quality of life in Egypt [40]. Demographic and clinical factors such as age, gender, severity of pain or disability influence help-seeking behavior for chronic diseases [41]. It has also been shown that psychosocial factors including past help seeking, outcome expectancy, age-related beliefs, social cost and social influence have great impact on individual seeking behavior [41]. A community awareness program could change our culture of silence on reproductive problems and as a result improve women's quality of life [5].

The main strength of the present study is its methodology, as it is a community based prevalence study carried out on an ethnically homogenous population and had an appropriate response rate of 88.8%. The similarity between the educational status and the prevalence of obesity in the present study and a national survey conducted by Janghorbani et al [42]could confirm our population as being representative of Iranian reproductive aged women. Reproductive morbidities in the present study were diagnosed through interviews in combination with physical examination and ultrasonography, making our results more reliable than those based on self reported questionnaires or interviews per se.

Our study does have some limitations; we did not use the menstrual diary to identify menstrual problems. Complementary laboratory methods were also not used for confirming diagnosis of pelvic infections due to cost containment. We did not have any information about the few women who refuse to participate in our study; however, considering our 90 percent response rate this could hardly affect our estimates.

Conclusion

Reproductive health morbidities impose a large burden among Iranian women and have negative impact on their reproductive health and wellbeing. The present study demonstrated that about one-third of Iranian women experienced at least one reproductive morbidity and a majority of them had not sought appropriate care. The challenge ahead is to modify and restructure the primary health care system based on modern concepts of reproductive health care that can accommodate the current needs of the community.

Declarations

Acknowledgements

We are indebted to each of the study participants for the substantial time and effort contributed to this study. Acknowledgments are also due to the research staff at the health departments of Ghazvin, Kermanshah, Golestan and Hormozgan provinces and personnel of the Research Endocrine Laboratory. My special thanks to Doctor Pesteie and Doctor Allameh for their important contribution on research coordination and to Mrs.N.Shiva for editing the manuscript. The authors also thank the National Council of Scientific Research of the I.R.Iran for approval of this project and its funding as a national research project.

Authors’ Affiliations

(1)
Associate professor, Reproductive Endocrinology Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Science
(2)
Associate professor, Department of Reproductive Health, Faculty of Nursing and Midwifery, Shahid Beheshti University of Medical Science
(3)
Faculty of Nursing and Midwifery of Shahid Beheshti Medical Science University (3th floor, Deputy of research)
(4)
Director for Department of Geriatric Health care Department, Deputy of Health, Ministry of Health and Medical Education

References

  1. Safe Motherhood: Surviving Childbirth, But Enduring Chronic Ill Health. Book Safe Motherhood: Surviving Childbirth, But Enduring Chronic Ill Health. 2009, City. United Nation Population Found
  2. Postpartum care of mother and newborn: a practical guide. Book Postpartum care of mother and newborn: a practical guide. 1998, City. World Health Organization
  3. Report on the Regional Reproductive Health Strategy Workshop, South East Asia Region. Book Report on the Regional Reproductive Health Strategy Workshop, South East Asia Region. 1995, City. World Health Organization
  4. Measuring reproductive morbidity. Report of technical working group. Book Measuring reproductive morbidity. Report of technical working group. 1990, City: World Health Organization
  5. Graham W, Berer M, Price J, Brabin L: Raising awareness about reproductive morbidity. Ann Trop Med Parasitol. 1992, 86 (Suppl 1): 11-18.PubMedGoogle Scholar
  6. Health and the Millennium Development Goals. Book Health and the Millennium Development Goals. Edited by: ed.^eds. 2005, City: World Health Organization
  7. Zurayk H, Khattab H, Younis N, Kamal O, el-Helw M: Comparing women's reports with medical diagnoses of reproductive morbidity conditions in rural Egypt. Stud Fam Plann. 1995, 26: 14-21. 10.2307/2138047.View ArticlePubMedGoogle Scholar
  8. Fang X, Zhou Y, Yang Y, Diao Y, Li H: Prevalence and risk factors of trichomoniasis, bacterial vaginosis, and candidiasis for married women of child-bearing age in rural Shandong. Jpn J Infect Dis. 2007, 60: 257-261.PubMedGoogle Scholar
  9. Samuelsson EC, Victor FT, Tibblin G, Svardsudd KF: Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol. 1999, 180: 299-305. 10.1016/S0002-9378(99)70203-6.View ArticlePubMedGoogle Scholar
  10. Mawajdeh SM, Al-Qutob R, Schmidt A: Measuring reproductive morbidity: a community-based approach, Jordan. Health Care Women Int. 2003, 24: 635-649. 10.1080/07399330390217734.View ArticlePubMedGoogle Scholar
  11. Sadana R: Measuring reproductive health: review of community-based approaches to assessing morbidity. Bull World Health Organ. 2000, 78: 640-654.PubMedPubMed CentralGoogle Scholar
  12. Walraven G, Scherf C, West B, Ekpo G, Paine K, Coleman R, Bailey R, Morison L: The burden of reproductive-organ disease in rural women in The Gambia, West Africa. Lancet. 2001, 357: 1161-1167. 10.1016/S0140-6736(00)04333-6.View ArticlePubMedGoogle Scholar
  13. Latthe P, Latthe M, Say L, Gulmezoglu M, Khan KS: WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health. 2006, 6: 177-10.1186/1471-2458-6-177.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Al-Riyami A, Afifi M, Morsi M, Mabry R: A national study of gynecological morbidities in Oman. Effect of women's autonomy. Saudi Med J. 2007, 28: 881-890.PubMedGoogle Scholar
  15. Koch LH: Help-seeking behaviors of women with urinary incontinence: an integrative literature review. J Midwifery Womens Health. 2006, 51: e39-44. 10.1016/j.jmwh.2006.06.004.View ArticlePubMedGoogle Scholar
  16. Yakong VN, Rush KL, Bassett-Smith J, Bottorff JL, Robinson C: Women's experiences of seeking reproductive health care in rural Ghana: challenges for maternal health service utilization. J Adv Nurs. 2010, 66: 2431-2441. 10.1111/j.1365-2648.2010.05404.x.View ArticlePubMedGoogle Scholar
  17. Sadeghi-Hassanabadi AKH, Setoudeh-Maram E, Sarraf Z: Prevalence of reproductive morbidity among women of the Qashqa'i tribe, Islamic Republic of Iran. Eastern Mediterranean Health Journal. 1998, 4: 312-318.Google Scholar
  18. Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, Shull BL, Smith AR: The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996, 175: 10-17. 10.1016/S0002-9378(96)70243-0.View ArticlePubMedGoogle Scholar
  19. WHO: Sexually Transmitted and Other Reproductive Tract Infections in Integrating STI/RTI Care for Reproductive Health. A guide to essential practice. 2005, Geneva: WHOGoogle Scholar
  20. Schmidt L, Munster K, Helm P: Infertility and the seeking of infertility treatment in a representative population. Br J Obstet Gynaecol. 1995, 102: 978-984. 10.1111/j.1471-0528.1995.tb10905.x.View ArticlePubMedGoogle Scholar
  21. Dawood MY: Dysmenorrhea. Clin Obstet Gynecol. 1990, 33: 168-178. 10.1097/00003081-199003000-00023.View ArticlePubMedGoogle Scholar
  22. Lurie S, Borenstein R: The premenstrual syndrome. Obstet Gynecol Surv. 1990, 45: 220-228. 10.1097/00006254-199004000-00003.View ArticlePubMedGoogle Scholar
  23. Treloar AE, Boynton RE, Behn BG, Brown BW: Variation of the human menstrual cycle through reproductive life. Int J Fertil. 1967, 12: 77-126.PubMedGoogle Scholar
  24. Chiazze L, Brayer FT, Macisco JJ, Parker MP, Duffy BJ: The length and variability of the human menstrual cycle. JAMA. 1968, 203: 377-380. 10.1001/jama.203.6.377.View ArticlePubMedGoogle Scholar
  25. Deeb ME AJ, Yeretzian JS, Kaspar HG: Prevalence of reproductive tract infections, genital prolapse, and obesity in a rural community in Lebanon. Bulletin of the World Health Organization. 2003, 81: 639-645.PubMedPubMed CentralGoogle Scholar
  26. Al Asya R, Afifi M, Fathalla MM: Gynecological and related morbidities among ever-married Omani women. Afr J Reprod Health. 2004, 8: 188-197. 10.2307/3583403.View ArticlePubMedGoogle Scholar
  27. Woolcock JG, Critchley HO, Munro MG, Broder MS, Fraser IS: Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding. Fertil Steril. 2008, 90: 2269-2280. 10.1016/j.fertnstert.2007.10.060.View ArticlePubMedGoogle Scholar
  28. Al-Qutob R, Mawajdeh S, Massad D: Can a home-based pelvic examination be used in assessing reproductive morbidity in population-based studies? A Jordanian experience. J Adv Nurs. 2001, 33: 603-612. 10.1046/j.1365-2648.2001.01707.x.View ArticlePubMedGoogle Scholar
  29. Sihavong A, Lundborg CS, Syhakhang L, Kounnavong S, Wahlstrom R, Freudenthal S: Community perceptions and treatment-seeking behaviour regarding reproductive tract infections including sexually transmitted infections in lao pdr: a qualitative study. J Biosoc Sci. 2011, 43: 285-303. 10.1017/S002193201000074X.View ArticlePubMedGoogle Scholar
  30. Vishwanath S, Talwar V, Prasad R, Coyaji K, Elias CJ, de Zoysa I: Syndromic management of vaginal discharge among women in a reproductive health clinic in India. Sex Transm Infect. 2000, 76: 303-306. 10.1136/sti.76.4.303.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Richardson K, Hagen S: The role of nurses in the management of women with pelvic organ prolapse. Br J Nurs. 2009, 18: 294-296. 298-300View ArticlePubMedGoogle Scholar
  32. Swift S, Woodman P, O'Boyle A, Kahn M, Valley M, Bland D, Wang W, Schaffer J: Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol. 2005, 192: 795-806. 10.1016/j.ajog.2004.10.602.View ArticlePubMedGoogle Scholar
  33. Dannecker C, Anthuber C: The effects of childbirth on the pelvic-floor. J Perinat Med. 2000, 28: 175-184. 10.1515/JPM.2000.025.View ArticlePubMedGoogle Scholar
  34. Swift SE, Tate SB, Nicholas J: Correlation of symptoms with degree of pelvic organ support in a general population of women: what is pelvic organ prolapse?. Am J Obstet Gynecol. 2003, 189: 372-377. 10.1067/S0002-9378(03)00698-7. discussion 377-379View ArticlePubMedGoogle Scholar
  35. Shamliyan T, Wyman J, Bliss DZ, Kane RL, Wilt TJ: Prevention of urinary and fecal incontinence in adults. Evid Rep Technol Assess (Full Rep). 2007, 1-379.Google Scholar
  36. O'Connor VM: Heavy menstrual loss - Part 1. Is it really heavy loss?. Medicine Today. 2003, 4: 51-60.Google Scholar
  37. Fraser IS, Critchley HO, Munro MG, Broder M: Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?. Hum Reprod. 2007, 22: 635-643.View ArticlePubMedGoogle Scholar
  38. Seck BC, Jackson RT: Determinants of compliance with iron supplementation among pregnant women in Senegal. Public Health Nutr. 2008, 11: 596-605.View ArticlePubMedGoogle Scholar
  39. Inhorn MC: Interpreting infertility: medical anthropological perspectives. Introduction. Soc Sci Med. 1994, 39: 459-461. 10.1016/0277-9536(94)90089-2.View ArticlePubMedGoogle Scholar
  40. Mohamed AM, Hassouna MS, Kassem MS: Gender differences in factors associated with patients' decisions to seek treatment for urinary incontinence in Alexandria, Egypt. East Mediterr Health J. 2010, 16: 1170-1182.PubMedGoogle Scholar
  41. Cornally N, McCarthy G: Help-seeking behaviour for the treatment of chronic pain. Br J Community Nurs. 2011, 16: 90-98.View ArticlePubMedGoogle Scholar
  42. Janghorbani M, Amini M, Willett WC, Mehdi Gouya M, Delavari A, Alikhani S, Mahdavi A: First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults. Obesity (Silver Spring). 2007, 15: 2797-2808. 10.1038/oby.2007.332.View ArticleGoogle Scholar
  43. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/11/863/prepub

Copyright

© Tehrani et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement